4.5 Article

Affective coding: the emotional dimension of agency

期刊

FRONTIERS IN HUMAN NEUROSCIENCE
卷 8, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnhum.2014.00608

关键词

agency; emotion; prediction; self-awareness; schizophrenia; cue integration; reward

资金

  1. European Platform for Life Sciences, Mind Sciences and Humanities
  2. Volkswagen Stiftung
  3. Deutsche Forschungsgemeinschaft (DFG)
  4. Open Access Publishing Fund of Tuebingen University

向作者/读者索取更多资源

The sense of agency (SoA) (i.e., the registration that I am the initiator and controller of my actions and relevant events) is associated with several affective dimensions. This makes it surprising that the emotion factor has been largely neglected in the field of agency research. Current empirical investigations of the SoA mainly focus on sensorimotor signals (i.e., efference copy) and cognitive cues (i.e., intentions, beliefs) and on how they are integrated. Here we argue that this picture is not sufficient to explain agency experience, since agency and emotions constantly interact in our daily life by several ways. Reviewing first recent empirical evidence, we show that self-action perception is in fact modulated by the affective valence of outcomes already at the sensorimotor level. We hypothesize that the affective coding between agency and action outcomes plays an essential role in agency processing, i.e., the prospective, immediate or retrospective shaping of agency representations by affective components. This affective coding of agency be differentially altered in various neuropsychiatric diseases (e.g., schizophrenia vs. depression), thus helping to explain the dysfunctions and content of agency experiences in these diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study

Tim W. Rattay, Maximilian Voelker, Maren Rautenberg, Christoph Kessler, Isabel Wurster, Natalie Winter, Tobias B. Haack, Tobias Lindig, Holger Hengel, Matthis Synofzik, Rebecca Schule, Peter Martus, Ludger Schoels

Summary: This study explores early changes in the most common subtype of hereditary spastic paraplegia, SPG4, and identifies subclinical markers of disease activity in the prodromal stage. The findings suggest that certain clinical signs, such as increased reflexes and muscle weakness, may be more frequent in individuals who carry the genetic mutation associated with SPG4.
Article Clinical Neurology

Home-based biofeedback speech treatment improves dysarthria in repeat-expansion SCAs

Adam P. Vogel, Lisa H. Graf, Michelle Magee, Ludger Schoels, Natalie Rommel, Matthis Synofzik

Summary: This study evaluated the efficacy of a home-delivered, ataxia-tailored biofeedback-driven speech therapy in individuals with CAG-SCA, and found that the treatment improved intelligibility in the patients.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2022)

Article Clinical Neurology

Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

Elizabeth Finger, Rubina Malik, Martina Bocchetta, Kristy Coleman, Caroline Graff, Barbara Borroni, Mario Masellis, Robert Laforce, Caroline Greaves, Lucy L. Russell, Rhian S. Convery, Arabella Bouzigues, David M. Cash, Markus Otto, Matthis Synofzik, James B. Rowe, Daniela Galimberti, Pietro Tiraboschi, Robert Bartha, Christen Shoesmith, Maria Carmela Tartaglia, John C. van Swieten, Harro Seelaar, Lize C. Jiskoot, Sandro Sorbi, Chris R. Butler, Alexander Gerhard, Raquel Sanchez-Valle, Alexandre de Mendonca, Fermin Moreno, Rik Vandenberghe, Isabelle Le Ber, Johannes Levin, Florence Pasquier, Isabel Santana, Jonathan D. Rohrer, Simon Ducharme

Summary: This study investigates the hypothesis that genetic mutations causing frontotemporal dementia (FTD) have neurodevelopmental consequences. The researchers examined brain structure and function in young adult mutation carriers and found differences between preclinical mutation carriers and familial non-carriers at a mean age of 26 years. These findings have implications for therapeutic interventions and further studies on early pathophysiologic processes in FTD.
Editorial Material Biochemistry & Molecular Biology

Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations

Annemieke Aartsma-Rus, Willeke van Roon-Mom, Marlen Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schuele, Matthis Synofzik, Holm Graessner

Summary: Splice-modulating antisense oligonucleotides (ASOs) provide treatment options for rare neurological diseases with rare mutations, and patient-specific ASOs need to be developed. The 1 Mutation 1 Medicine (1M1M) and Dutch Center for RNA Therapeutics (DCRT) aim to develop and treat eligible patients with patient-specific ASOs in Europe and the Netherlands, respectively, under a named patient setting.
Article Neurosciences

Speech and Nonspeech Parameters in the Clinical Assessment of Dysarthria: A Dimensional Analysis

Wolfram Ziegler, Theresa Schoelderle, Bettina Brendel, Verena Risch, Stefanie Felber, Katharina Ott, Georg Goldenberg, Mathias Vogel, Kai Boetzel, Lena Zettl, Stefan Lorenzl, Renee Lampe, Katrin Strecker, Matthis Synofzik, Tobias Lindig, Hermann Ackermann, Anja Staiger

Summary: This study investigated the relationship between commonly used nonspeech parameters in clinical dysarthria assessment and the speech characteristics of dysarthria in individuals with movement disorders. The findings suggest that the nonspeech parameters currently used in dysarthria diagnostics do not align with diagnostic measures of speech characteristics in individuals with dysarthria.

BRAIN SCIENCES (2023)

Letter Clinical Neurology

Short-read genome sequencing allows 'en route' diagnosis of patients with atypical Friedreich ataxia

Zofia Fleszar, Claudia Dufke, Marc Sturm, Rebecca Schuele, Ludger Schoels, Tobias B. Haack, Matthis Synofzik

JOURNAL OF NEUROLOGY (2023)

Article Health Care Sciences & Services

SARAspeech-Feasibility of automated assessment of ataxic speech disturbance

M. Grobe-Einsler, J. Faber, A. Taheri, J. Kybelka, J. Raue, J. Volkening, F. Helmhold, M. Synofzik, T. Klockgether

Summary: Ataxias refer to a group of movement disorders, characterized by progressive loss of balance, impaired coordination, and speech disturbance, resulting in a significant reduction in quality of life. Although speech disturbance can be clinically diagnosed, there is a lack of objective methods for assessing its severity. Through the analysis of 71 sets of speech recordings from ataxia patients, an automated classification system was developed. This system correctly predicted the expert ratings of speech disturbance in 80% of cases, demonstrating the feasibility of computer-assisted voice analysis for automated assessment of speech disturbance severity.

NPJ DIGITAL MEDICINE (2023)

Article Clinical Neurology

Structural correlates of language processing in primary progressive aphasia

Curtiss A. Chapman, Maryna Polyakova, Karsten Mueller, Christopher Weise, Klaus Fassbender, Klaus Fliessbach, Johannes Kornhuber, Martin Lauer, Sarah Anderl-Straub, Albert Ludolph, Johannes Prudlo, Anja Staiger, Matthis Synofzik, Jens Wiltfang, Lina Riedl, Janine Diehl-Schmid, Markus Otto, Adrian Danek, Gesa Hartwigsen, Matthias L. Schroeter

Summary: Understanding the relationship between brain structure and language behavior in primary progressive aphasia is crucial for understanding the pathomechanisms of these diseases. This study found that there are networks of language task-associated brain regions, some of which show atrophy and others do not, suggesting regions of future network disruption and providing insights into task deficits beyond atrophied cortex.

BRAIN COMMUNICATIONS (2023)

Article Cell Biology

Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3

David Mengel, Isabel G. Wellik, Kristen H. Schuster, Sabrina I. Jarrah, Madeleine Wacker, Naila S. Ashraf, Gulin Oez, Matthis Synofzik, Maria do Carmo Costa, Hayley S. Mcloughlin

Summary: The study found that blood NfL levels gradually increase in a SCA3 mouse model during disease progression, and are associated with motor deficits and neurometabolite abnormalities related to ataxia. This further supports the utility of blood NfL as a peripheral biomarker for neurodegenerative diseases, and provides a timeline for different measures of SCA3 pathogenesis.

DISEASE MODELS & MECHANISMS (2023)

Letter Clinical Neurology

As Frequent as Polyglutamine Spinocerebellar Ataxias: SCA27B in a Large German Autosomal Dominant Ataxia Cohort

Holger Hengel, David Pellerin, Carlo Wilke, Zofia Fleszar, Bernard Brais, Tobias Haack, Andreas Traschuetz, Ludger Schoels, Matthis Synofzik

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Frequency and Phenotype of RFC1 Repeat Expansions in Bilateral Vestibulopathy

Andreas Traschuetz, Felix Heindl, Muhammad Bilal, Annette M. Hartmann, Claudia Dufke, Olaf Riess, Andreas Zwergal, Dan Rujescu, Tobias Haack, Matthis Synofzik, Michael Strupp

Summary: Bilateral vestibulopathy is a chronic neurological disorder with unknown monogenic cause. This study identifies replication factor complex subunit 1 repeat expansions as a common cause of the disease and provides detailed characterization of its features and progression.

NEUROLOGY (2023)

Article Biology

Altered brain dynamics index levels of arousal in complete locked-in syndrome

Federico Zilio, Javier Gomez-Pilar, Ujwal Chaudhary, Stuart Fogel, Tatiana Fomina, Matthis Synofzik, Ludger Schols, Shumei Cao, Jun Zhang, Zirui Huang, Niels Birbaumer, Georg Northoff

Summary: EEG-based measures such as power-law exponent (PLE) and Lempel-Ziv complexity (LZC) can be used to identify biomarkers associated with complete locked-in syndrome (CLIS), allowing for better treatment and communication options.

COMMUNICATIONS BIOLOGY (2023)

Article Clinical Neurology

Comparison of Live and Remote Video Ratings of the Scale for Assessment and Rating of Ataxia

Arian Taheri Amin, Jennifer Faber, Demet Onder, Okka Kimmich, Matthis Synofzik, Tetsuo Ashizawa, Thomas Klockgether, Marcus Grobe-Einsler

Summary: After conducting comprehensive SARA assessments on video recordings of 69 patients with cerebellar ataxia, it was found that there was a high level of agreement between live ratings by site investigators and remote video ratings by experienced ataxia clinicians, indicating that remote video ratings are a reliable means to assess the severity of ataxia.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients

Catherine Ashton, Elisabetta Indelicato, David Pellerin, Guillemette Clement, Matt C. Danzi, Marie-Josee Dicaire, Celine Bonnet, Henry Houlden, Stephan Zuechner, Matthis Synofzik, Phillipa J. Lamont, Mathilde Renaud, Sylvia Boesch, Bernard Brais

Summary: Ashton C et al report a retrospective multi-centre cohort study of 34 patients from Canada, France, Austria and Australia with spinocerebellar ataxia 27B. The study describes the common feature of episodic ataxia and other episodic features, and also highlights the ineffectiveness of acetazolamide in these patients.

BRAIN COMMUNICATIONS (2023)

Article Neurosciences

Standards of Fluid Biomarker Collection and Pre-analytical Processes in Humans and Mice: Recommendations by the Ataxia Global Initiative Working Group on Biomarkers

Filippo Santorelli, Hayley McLoughlin, Justin Wolter, Daniele Galatolo, Matthis Synofzik, David Mengel, Puneet Opal

Summary: The Ataxia Global Initiative (AGI) aims to facilitate clinical trial readiness for hereditary ataxias by addressing the lack of objective measures for disease study and treatment evaluation. The AGI fluid biomarker working group has developed protocols to standardize sampling and storage of biomarkers for both human and mouse studies, with the goal of reducing variability and improving statistical power in downstream analysis. Emphasis has been placed on harmonizing minimal biological sample collection and storage, while optional protocols are available for advanced biofluid processing and storage.

CEREBELLUM (2023)

暂无数据